ClinicalTrials.gg
Sign In
CompletedNCT06157775Updated Dec 6, 2023

Shear-wave Elastography of Hip Stabilizers in Healthy Individuals

An observational study in Shear-wave Elastography of Hip Stabilizers in Healthy Individuals, sponsored by Koç University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-06.

Sponsored by Koç University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
12
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The aim of this study is to provide a scientific basis for Shear-wave elastography measurements of hip stabilizing muscles on healthy individuals. To assess the inter- and intra-user validity, 12 healthy volunteers were recruited for ultrasonographic assessment by two experienced physiatrists.

02

Conditions studied

  • Shear-wave Elastography of Hip Stabilizers in Healthy Individuals
03

In context

Lead sponsor

Koç University is the lead sponsor of 109 studies on the registry; 36 are open to participants now.

Browse Koç University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

12 Healthy Individuals, 4 male and 8 female.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy Individuals
  • Age 18-30 years
  • Volunteering for the study
  • Absence of musculoskeletal pathologies involving pelvic, hip, and/or knee joints.

Exclusion criteria

Exclusion Criteria:

  • Recent complaints of pelvic, hip, and/or knee pain.
  • Previous history of trauma or surgery, including the lumbar, pelvic, hip, or knee region.
  • Congenital or acquired pathologies of pelvis or lower extremity.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy Individuals

    Diagnostic Test: Shear-wave elastography

Interventions

  • Diagnostic testShear-wave elastography

    Shear-wave elastography using a manual ultrasound with a 9L-Probe in B-mode.

06

What researchers measure

Primary outcomes

  1. Assessment of tensor fascia latae muscle on shear wave elastography.

    Time frame: 1 month

  2. Assessment of gluteus medius muscle on shear wave elastography.

    Time frame: 1 month

  3. Assessment of iliotibial band on shear wave elastography.

    Time frame: 1 month

07

Study locations

1 site
  • Koc University School of Medicine
    Istanbul, 34010, Turkey (Türkiye)
08

References and documents

Publications

  • Cortez CD, Hermitte L, Ramain A, Mesmann C, Lefort T, Pialat JB. Ultrasound shear wave velocity in skeletal muscle: A reproducibility study. Diagn Interv Imaging. 2016 Jan;97(1):71-9. doi: 10.1016/j.diii.2015.05.010. Epub 2015 Jun 25. PubMed 26119864 ↗
  • Iida N, Kuroiwa T, Amadio P. Analysis of the thenar muscles with ultrasound shear wave elastography: Reliability and preliminary findings. Muscle Nerve. 2024 Jan;69(1):72-77. doi: 10.1002/mus.28004. Epub 2023 Nov 15. PubMed 37964671 ↗
  • Whittaker JL, Emery CA. Sonographic measures of the gluteus medius, gluteus minimus, and vastus medialis muscles. J Orthop Sports Phys Ther. 2014 Aug;44(8):627-32. doi: 10.2519/jospt.2014.5315. Epub 2014 Jul 16. PubMed 25029916 ↗
  • Vuorenmaa AS, Siitama EMK, Makela KS. Inter-operator and inter-device reproducibility of shear wave elastography in healthy muscle tissues. J Appl Clin Med Phys. 2022 Sep;23(9):e13717. doi: 10.1002/acm2.13717. Epub 2022 Jul 6. PubMed 35793227 ↗
  • Gyaran IA, Spiezia F, Hudson Z, Maffulli N. Sonographic measurement of iliotibial band thickness: an observational study in healthy adult volunteers. Knee Surg Sports Traumatol Arthrosc. 2011 Mar;19(3):458-61. doi: 10.1007/s00167-010-1269-z. Epub 2010 Oct 2. PubMed 20890700 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2019 to primary completion in Dec 2019, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2023
First posted
Dec 6, 2023
StartActual
Oct 31, 2019
Primary completionActual
Dec 31, 2019
CompletionActual
Dec 31, 2019
Last update
Dec 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06157775
Lead sponsor
Koç University
Responsible party
Sponsor
First posted
Dec 6, 2023
Start date
Oct 31, 2019
Primary completion
Dec 31, 2019
Completion
Dec 31, 2019
Last update
Dec 6, 2023

Study contacts

Ozden Ozyemisci Taskiran, MD
principal investigator · Koc University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Koç University →

Start the discussion